An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome StudyMichael Proctor, Donald C. McMillan|British Journal of Cancer|2011Cited by 526
Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal CancerYoshinaga Okugawa, Masato Kusunoki, Koji Tanaka et al.|Annals of Surgery|2019Cited by 298
Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancerYoshinaga Okugawa, Masato Kusunoki, Yuji Toiyama et al.|Clinical Nutrition|2019Cited by 144
The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancerZ M A Mohammed, Donald C. McMillan|British Journal of Cancer|2013Cited by 134
Prognostic role of preoperative circulating systemic inflammatory response markers in primary breast cancer: meta-analysisFrancesca Savioli, Donald C. McMillan|British journal of surgery|2022Cited by 77